Budde K - Search Results

1

A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection.

Doberer K, Duerr M, Halloran PF, Eskandary F, Budde K, Regele H, Reeve J, Borski A, Kozakowski N, Reindl-Schwaighofer R, Waiser J, Lachmann N, Schranz S, Firbas C, Mühlbacher J, Gelbenegger G, Perkmann T, Wahrmann M, Kainz A, Ristl R, Halleck F, Bond G, Chong E, Jilma B, Böhmig GA. Doberer K, et al. Among authors: budde k. J Am Soc Nephrol. 2021 Mar;32(3):708-722. doi: 10.1681/ASN.2020071106. Epub 2020 Dec 18. J Am Soc Nephrol. 2021. PMID: 33443079 Free PMC article. Clinical Trial.

2

First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients.

Budde K, Schmouder RL, Brunkhorst R, Nashan B, Lücker PW, Mayer T, Choudhury S, Skerjanec A, Kraus G, Neumayer HH. Budde K, et al. J Am Soc Nephrol. 2002 Apr;13(4):1073-1083. doi: 10.1681/ASN.V1341073. J Am Soc Nephrol. 2002. PMID: 11912269 Clinical Trial.

3

Impact of the variability of cyclosporin A trough levels on long-term renal allograft function.

Waiser J, Slowinski T, Brinker-Paschke A, Budde K, Schreiber M, Böhler T, Hauser I, Neumayer HH. Waiser J, et al. Among authors: budde k. Nephrol Dial Transplant. 2002 Jul;17(7):1310-7. doi: 10.1093/ndt/17.7.1310. Nephrol Dial Transplant. 2002. PMID: 12105257

4

Cyclosporine A up-regulates the expression of TGF-beta1 and its receptors type I and type II in rat mesangial cells.

Waiser J, Dell K, Böhler T, Dogu E, Gaedeke J, Budde K, Neumayer HH. Waiser J, et al. Among authors: budde k. Nephrol Dial Transplant. 2002 Sep;17(9):1568-77. doi: 10.1093/ndt/17.9.1568. Nephrol Dial Transplant. 2002. PMID: 12198207

5

Impact of PGE1 on cyclosporine A induced up-regulation of TGF-beta1, its receptors, and related matrix production in cultured mesangial cells.

Dell K, Böhler T, Gaedeke J, Budde K, Neumayer HH, Waiser J. Dell K, et al. Among authors: budde k. Cytokine. 2003 Jun 21;22(6):189-93. doi: 10.1016/s1043-4666(03)00151-0. Cytokine. 2003. PMID: 12890451

6

The value of C2 monitoring in stable renal allograft recipients on maintenance immunosuppression.

Einecke G, Mai I, Fritsche L, Slowinski T, Waiser J, Neumayer HH, Budde K. Einecke G, et al. Among authors: budde k. Nephrol Dial Transplant. 2004 Jan;19(1):215-22. doi: 10.1093/ndt/gfg434. Nephrol Dial Transplant. 2004. PMID: 14671060

7

The immunosuppressive potential of misoprostol--efficacy and variability.

Waiser J, Böhler T, Stoll J, Schumann B, Budde K, Neumayer HH. Waiser J, et al. Among authors: budde k. Clin Immunol. 2003 Dec;109(3):288-94. doi: 10.1016/j.clim.2003.08.009. Clin Immunol. 2003. PMID: 14697743

8

FTY720 exerts differential effects on CD4+ and CD8+ T-lymphocyte subpopulations expressing chemokine and adhesion receptors.

Böhler T, Waiser J, Schuetz M, Neumayer HH, Budde K. Böhler T, et al. Among authors: budde k. Nephrol Dial Transplant. 2004 Mar;19(3):702-13. doi: 10.1093/ndt/gfg599. Nephrol Dial Transplant. 2004. PMID: 14767029 Clinical Trial.

9

FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.

Dragun D, Böhler T, Nieminen-Kelhä M, Waiser J, Schneider W, Haller H, Luft FC, Budde K, Neumayer HH. Dragun D, et al. Among authors: budde k. Kidney Int. 2004 Mar;65(3):1076-83. doi: 10.1111/j.1523-1755.2004.00478.x. Kidney Int. 2004. PMID: 14871428 Free article.

10

Review of the immunosuppressant enteric-coated mycophenolate sodium.

Budde K, Glander P, Diekmann F, Waiser J, Fritsche L, Dragun D, Neumayer HH. Budde K, et al. Expert Opin Pharmacother. 2004 Jun;5(6):1333-45. doi: 10.1517/14656566.5.6.1333. Expert Opin Pharmacother. 2004. PMID: 15163278 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

694 results

Search Page

Filters